Final Alert: New Marijuana Stock Posting Tomorrow at 11:05 am ET

[Zacks | Our Research. Your Success.] Last Chance to Beat Wall Street to This Ticker {NAME}, Did you miss my earlier email? I want to give you one more chance to ride the historic growth trajectory of legal marijuana from $20.5 billion back in 2020 as it explodes to an expected $90.4 billion by 2026. In my view, these numbers are very conservative. We're on the brink of legalizing marijuana on the Federal level, and this would open the floodgates. Many U.S. companies could then list on exchanges like NYSE and Nasdaq, and money will flow. The entire industry is set to ignite. Medicinal marijuana is already legal in 36 states with 18 allowing recreational use. It's already legal in Canada and there's movement in Mexico and throughout Europe. Most marijuana stocks are still trading at big discounts. Time to get aboard. Zacks' Marijuana Innovators portfolio is taking full advantage of what is shaping up to be a generational opportunity. We recently closed gains of +39.7%, +94.5%, even +147.0% in as little as 4½ months.¹ I should mention that our approach avoids the dicey penny stocks, targeting the few growers, pharmaceuticals, financial firms, suppliers - both established and start-ups - that are the true innovators. It offers the most reliable potential for double and triple-digit gains. Plus, tomorrow morning, I'll post a new marijuana stock that offers tremendous promise. Don't miss this chance to get in early. It couldn't be easier to gain 30-day access to the buys, sells, and commentary of our Marijuana Innovators portfolio. Your total cost? Only $1. Bonus Report: Speaking of industries with explosive growth potential, you are also invited to download our Special Report, One Semiconductor Stock Stands to Gain the Most. From 35 semiconductor stocks, you can get an early look at Zacks' top pick during today's chip shortage crisis. Important Reminder: We can't allow too many investors to jump on our selected marijuana stocks. The deadline for entry is midnight Sunday, December 26 - tonight. [▶ See Stocks Now]( All the best, [Ben Rains - signature] Ben Rains Editor of Marijuana Innovators ¹ The results listed above are not (or may not be) representative of the performance of all selections made by Zacks Investment Research's newsletter editors and may represent the partial close of a position. This free resource is being sent by [Zacks.com](). We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms of Service". Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research is not a licensed securities dealer, broker or US investment adviser or investment bank. The Zacks #1 Rank Performance covers the period beginning on January 1, 1988 through December 6, 2021. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank #1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed above. Zacks Emails If you would prefer to not receive future profit-producing emails from [Zacks.com]() the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please [click here]( and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com. Zacks Investment Research 10 S. Riverside Plaza, Suite 1600 Chicago, IL 60606